Tag Archives: Xeloda

FDA Approves Halaven for Late-Stage Breast Cancer

Good news for patients with late stage metastatic breast cancer.  The US Food and Drug Administration (FDA) approved eribulin mesylate injection (Halaven; Eisai, Inc) for the treatment of metastatic breast cancer in patients who have received at least 2 prior … Continue reading

Posted in Breast cancer, Cancer | Tagged , , , , , , , , , , , , , , , | Comments Off on FDA Approves Halaven for Late-Stage Breast Cancer

HER2-positive Breast Cancer with Brain Metastases? Use Lapitinibi (Tykerb) and Capecitibine (Xeloda) but NOT Trastuzumab (Herceptin)

Human epidermal growth factor receptor 2-positive (HER2+) breast cancer (BC) is a disease that accounts for up to one third of all invasive breast tumors. The natural history of this disease, however, has been dramatically improved with the introduction of … Continue reading

Posted in Breast cancer, Cancer | Tagged , , , , , , , , , , | Comments Off on HER2-positive Breast Cancer with Brain Metastases? Use Lapitinibi (Tykerb) and Capecitibine (Xeloda) but NOT Trastuzumab (Herceptin)

A New Treatment Option for patients with Gastric Cancer

 Gastric cancer is the fourth most commonly diagnosed cancer and the second most common cause of cancer-related deaths worldwide.  Previous study has found that patients with operable disease have a 5-year survival rate of 36%.  In patients with advanced or … Continue reading

Posted in Cancer, Gastric Cancer | Tagged , , , , , , , , , | Comments Off on A New Treatment Option for patients with Gastric Cancer

Efficacy and tolerability of Avastin plus Xeloda as first-line therapy in patients with advanced Liver Cancer

Liver cancer is the fifth most common cancer worldwide and the third most common cause of cancer mortality.  More than 80% of cases occur in East Asia and sub-Sharan Africa, and the incidence is increasing in Europe and the US. … Continue reading

Posted in Cancer, Liver Cancer | Tagged , , , , , , , | Comments Off on Efficacy and tolerability of Avastin plus Xeloda as first-line therapy in patients with advanced Liver Cancer

Standard Chemo Better Than Oral Capecitabine in Elderly Breast Cancer

Most elderly breast cancer patients would prefer oral chemotherapy such as capecitabine (Xeloda, Roche) over intravenous chemotherapy due to the convenience.  However, a clinical trial conducted in elderly women with early-stage breast cancer has found that standard adjuvant combination chemotherapy … Continue reading

Posted in Breast cancer, Cancer | Tagged , , , , , , , , , | Comments Off on Standard Chemo Better Than Oral Capecitabine in Elderly Breast Cancer

Pancreatic cancer – Causes, Prevention, Prognosis, Diagnosis and Latest Treatment

Prevalence Pancreatic cancer is the fourth most common cause of adult cancer death, accounting for an estimated 42,470 new cases and 35,240 deaths in USA for 2009.  The high mortality rate is due to the high incidence of metastatic disease … Continue reading

Posted in Pancreatic Cancer | Tagged , , , , , , , , , , , , , , , , | 2 Comments